Definitive Healthcare Corp (DH)vsVeeva Systems Inc Class A (VEEV)
DH
Definitive Healthcare Corp
$0.76
-1.14%
HEALTHCARE · Cap: $85.30M
VEEV
Veeva Systems Inc Class A
$172.61
-3.35%
HEALTHCARE · Cap: $25.92B
Smart Verdict
WallStSmart Research — data-driven comparison
Veeva Systems Inc Class A generates 1293% more annual revenue ($3.32B vs $238.26M). VEEV leads profitability with a 28.4% profit margin vs -71.5%. VEEV earns a higher WallStSmart Score of 71/100 (B).
DH
Hold37
out of 100
Grade: F
VEEV
Strong Buy71
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+78.5%
Fair Value
$7.87
Current Price
$0.76
$7.11 discount
Margin of Safety
+39.3%
Fair Value
$291.76
Current Price
$172.61
$119.15 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Strong operational efficiency at 30.9%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Keeps 28 of every $100 in revenue as profit
Growing faster than its price suggests
16.3% revenue growth
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
ROE of -116.5% — below average capital efficiency
Moderate valuation
Comparative Analysis Report
WallStSmart ResearchBull Case : DH
The strongest argument for DH centers on Price/Book.
Bull Case : VEEV
The strongest argument for VEEV centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 28.4% and operating margin at 30.9%. Revenue growth of 16.3% demonstrates continued momentum.
Bear Case : DH
The primary concerns for DH are EPS Growth, Market Cap, Debt/Equity.
Bear Case : VEEV
The primary concerns for VEEV are P/E Ratio.
Key Dynamics to Monitor
DH profiles as a turnaround stock while VEEV is a growth play — different risk/reward profiles.
DH carries more volatility with a beta of 1.33 — expect wider price swings.
VEEV is growing revenue faster at 16.3% — sustainability is the question.
VEEV generates stronger free cash flow (1.1B), providing more financial flexibility.
Bottom Line
VEEV scores higher overall (71/100 vs 37/100), backed by strong 28.4% margins and 16.3% revenue growth. DH offers better value entry with a 78.5% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Definitive Healthcare Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Definitive Healthcare Corp (DH) is a premier provider of comprehensive data and analytics solutions tailored for the healthcare sector, serving a broad spectrum of clients, including pharmaceutical firms, payers, and healthcare providers. The company leverages vast datasets and advanced real-time analytics to drive operational efficiency and provide strategic insights, ultimately enhancing patient outcomes. Positioned at the forefront of a rapidly evolving healthcare landscape, Definitive Healthcare is dedicated to delivering innovative, data-centric solutions that not only optimize operational performance but also confer competitive advantages to its partners. As demand for sophisticated healthcare analytics surges, DH is poised to be an influential player in redefining healthcare delivery.
Visit Website →Veeva Systems Inc Class A
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?